Citius Oncology, Inc. SEC filings CTOR
Citius Oncology, Inc. has 268 filings in SEC EDGAR's recent list, going back to May 19, 2021. Its latest annual report, Form ARS, was filed on Aug 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Aug 14, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| 4/A | Ownership document | Dec 22, 2025 | Sep 19, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 17, 2025 | — |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| 4/A | Filing | Dec 1, 2025 | Sep 19, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 12, 2025 | — |
| 4 | Insider transaction | Aug 7, 2025 | Jul 28, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 25, 2025 | — |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 5, 2024 | — |
| 4/A | Filing | Aug 30, 2024 | Aug 12, 2024 |
| 4/A | Filing | Aug 30, 2024 | Aug 12, 2024 |
| 4/A | Filing | Aug 30, 2024 | Aug 12, 2024 |
| 4/A | Filing | Aug 30, 2024 | Aug 12, 2024 |
| SC 13D | Ownership over 5% (active) | Aug 16, 2024 | — |
| 4 | Insider transaction | Aug 16, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 16, 2024 | Aug 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 15, 2024 | — |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| SC 13D | Ownership over 5% (active) | Oct 28, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Oct 20, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Oct 19, 2022 | — |
| 3 | Initial insider ownership | Oct 13, 2022 | Oct 13, 2022 |
| 3 | Initial insider ownership | Oct 13, 2022 | Oct 13, 2022 |
| 3 | Initial insider ownership | Oct 13, 2022 | Oct 13, 2022 |
| 3 | Initial insider ownership | Oct 13, 2022 | Oct 13, 2022 |
| 3 | Initial insider ownership | Oct 13, 2022 | Oct 13, 2022 |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTOR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Cranford, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1851484
- Former names
- TenX Keane Acquisition (until Aug 5, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.